Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease
Michael D. Kappelman, Kimberly N. Weaver, Margie Boccieri, Ann M. Firestine, Xian Zhang, Millie D. Long, Kelly Chun, M. Fernando, Michael Zikry, Xiangfeng Dai, Runa Watkins, J. Adler, Marla C. Dubinsky, Arthur Kastl, Athos Bousvaros, Jennifer Strople, Raymond K. Cross, Peter Higgins, Ryan C. Ungaro, Meenakshi Bewtra, Emanuelle Bellaguarda, Francis A. Farraye
Topics & Concepts
Immune systemInflammatory bowel diseaseCoronavirus disease 2019 (COVID-19)ImmunologyMedicineMessenger RNADiseaseVirologyBiologyInfectious disease (medical specialty)Internal medicineGeneBiochemistrySARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyInflammatory Bowel Disease